Bill Text: MN SF4058 | 2023-2024 | 93rd Legislature | Introduced


Bill Title: Commissioner of human services authorization to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases

Spectrum: Slight Partisan Bill (Democrat 2-1)

Status: (Introduced - Dead) 2024-02-22 - Referred to Health and Human Services [SF4058 Detail]

Download: Minnesota-2023-SF4058-Introduced.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.
feedback